Ellevest, Inc. Novavax Inc Transaction History

Ellevest, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$36.28 - $75.29 $943 - $1,957	-26 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$69.73 - $142.9 $8,437 - $17,290	-121 Reduced 82.31%	26 $2,000
Q4 2021 Jan 24, 2022	BUY	$134.56 - $217.97 $18,300 - $29,643	136 Added 1236.36%	147 $21,000
Q3 2021 Oct 19, 2021	BUY	$177.8 - $270.58 $1,955 - $2,976	11 New	11 $2,000
Q2 2021 Jul 13, 2021	SELL	$121.0 - $257.67 $968 - $2,061	-8 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$112.98 - $319.93 $903 - $2,559	8 New	8 $1,000
Q4 2020 Feb 04, 2021	SELL	$78.74 - $139.5 $1,653 - $2,929	-21 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$79.44 - $178.51 $1,112 - $2,499	14 Added 200.0%	21 $2,000
Q1 2020 Apr 13, 2020	BUY	$3.93 - $16.0 $27 - $112	7 New	7 $0

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.